FDA Inspection 901726 — Mid-America Transplant Services

Mid-America Transplant Services — FEI 3001238381

The FDA completed an inspection of Mid-America Transplant Services on October 30, 2014 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 30, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Saint Louis, MO (United States)